CS logo
small CS logo
Charité Campus Benjamin Franklin, Medizinische Klinik I

Berlin, Germany
Hospital department in Berlin
Hindenburgdamm 30, 12203 Berlin

About Charité Campus Benjamin Franklin, Medizinische Klinik I


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Charité Campus Benjamin Franklin, Medizinische Klinik I


During the past decade, Charité Campus Benjamin Franklin, Medizinische Klinik I conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Charité Campus Benjamin Franklin, Medizinische Klinik I" #1 collaborator was "AIO-Studien-gGmbH" with 1 trials as a collaborator and "Johannes Gutenberg University Mainz" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Charité Campus Benjamin Franklin, Medizinische Klinik I


According to Clinical.Site data, the most researched conditions in "Charité Campus Benjamin Franklin, Medizinische Klinik I" are "Adenocarcinoma of Stomach or Esophagogastric Junction" (1 trials), "Hepatitis B, Chronic" (1 trials), "Kidney Disease, Chronic" (1 trials) and "Ulcerative Colitis" (1 trials). Many other conditions were trialed in "Charité Campus Benjamin Franklin, Medizinische Klinik I" in a lesser frequency.

Clinical Trials Intervention Types at Charité Campus Benjamin Franklin, Medizinische Klinik I


Most popular intervention types in "Charité Campus Benjamin Franklin, Medizinische Klinik I" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cetuximab IF" (1 trials), "Methoxy polyethylene glycol-epoetin beta" (1 trials), "PENTAX EC-3870CIFK / EC-3870CILK confocal colonoscopes" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Charité Campus Benjamin Franklin, Medizinische Klinik I


The vast majority of trials in "Charité Campus Benjamin Franklin, Medizinische Klinik I" are 4 trials for "All" genders.

Clinical Trials Status at Charité Campus Benjamin Franklin, Medizinische Klinik I


Currently, there are NaN active trials in "Charité Campus Benjamin Franklin, Medizinische Klinik I". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Charité Campus Benjamin Franklin, Medizinische Klinik I, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Charité Campus Benjamin Franklin, Medizinische Klinik I, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".